Objective To investigate the correlation between the quality of life(QOL)and social supports in the patients with hematological malignancy.
目的分析恶性血液病患者的生活质量及其与社会支持的相关性。
参考来源 - 恶性血液病患者生活质量及其与社会支持的相关性Allo-geneic bone marrow transplantation(allo-BMT) has been accepted as the most effective treatment for many hematologic malignancies,aplastic anemia and inherited disease.
异基因骨髓移植(allo-BMT)是目前治疗恶性血液病、再生障碍性贫血,以及遗传性疾病等的最有效方法。
参考来源 - TJU103联合CTLA4Up to now , aged malignant hematonosis is still an uncurable disease , the therapeutic efficacy is not so satisfaction.
迄今为止,老年恶性血液病仍属不可治愈的疾病,目前的临床治疗效果尚不理想。
参考来源 - 老年恶性血液病与肾虚血瘀相关性研究OBJECTIVE To evaluate the effects and complications of Allogeneic peripheral blood stem cell transplantation(Allo-PBSCT) in the treatment of patients with hematologic malignancy.
目的 评价异基因外周血干细胞移植治疗恶性血液病的疗效及其并发症。
参考来源 - 异基因外周血干细胞移植29例临床分析·2,447,543篇论文数据,部分数据来源于NoteExpress
方法对恶性血液病合并二重感染的临床资料进行回顾分析。
Methods the clinical data of the malignant blood diseases were reviewed.
目的研究伊曲康唑治疗恶性血液病合并侵袭性真菌感染的疗效。
Objective to investigate the efficacy of itraconazole in the treatment of malignant hematological diseases with invasive fungal infections.
目的:评价帕罗西汀治疗恶性血液病伴发焦虑抑郁症状的疗效。
AIM: to evaluate clinical effectiveness of paroxetine in treating symptoms of depression and anxiety in patients with malignant hematological diseases.
应用推荐